title: A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.
authors.affiliation: NHS Centre for Reviews and Dissemination, The University of York, UK.
authors.forename: M S
authors.initials: MS
authors.lastname: McDonagh
authors.forename: L M
authors.initials: LM
authors.lastname: Bachmann
authors.forename: S
authors.initials: S
authors.lastname: Golder
authors.forename: J
authors.initials: J
authors.lastname: Kleijnen
authors.forename: G
authors.initials: G
authors.lastname: ter Riet
mesh_terms: D000085:Acetates / Q000627:therapeutic use; D000789:Angina, Unstable / Q000188:drug therapy*; D001713:Biphenyl Compounds / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D008297:Male; D010091:Oximes / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000191:economics / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000085:Acetates; D001713:Biphenyl Compounds; D010091:Oximes; D010455:Peptides; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D011759:Pyrrolidines; C107918:lefradafiban; D014443:Tyrosine; C084062:lamifiban; D000077466:Tirofiban; D000077542:Eptifibatide; C100917:sibrafiban